Login / Signup

Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study.

Ingrid HokstadGia DeyabMorten Wang FagerlandTorstein LybergGunnbjørg HjeltnesØystein FørreStefan AgewallTom Eirik MollnesIvana Hollan
Published in: PloS one (2019)
Clinical Trials (NCT00902005), retrospectively registered on the 14th of May 2009.
Keyphrases
  • clinical trial
  • rheumatoid arthritis
  • phase ii
  • randomized controlled trial
  • double blind
  • study protocol